Masoud Farshbaf

1.6k total citations
22 papers, 1.2k citations indexed

About

Masoud Farshbaf is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Masoud Farshbaf has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biomedical Engineering, 11 papers in Biomaterials and 10 papers in Molecular Biology. Recurrent topics in Masoud Farshbaf's work include Nanoparticle-Based Drug Delivery (11 papers), RNA Interference and Gene Delivery (8 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Masoud Farshbaf is often cited by papers focused on Nanoparticle-Based Drug Delivery (11 papers), RNA Interference and Gene Delivery (8 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Masoud Farshbaf collaborates with scholars based in Iran, United States and United Arab Emirates. Masoud Farshbaf's co-authors include Abolfazl Akbarzadeh, Soodabeh Davaran, Nasim Annabi, Roya Salehi, Hadi Valizadeh, Solmaz Mojarad-Jabali, Rovshan Khalilov, Yunes Panahi, Amir Zarebkohan and Siamak Saghfi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Functional Materials and Cancer Research.

In The Last Decade

Masoud Farshbaf

22 papers receiving 1.2k citations

Peers

Masoud Farshbaf
Chang‐Moon Lee South Korea
Masoud Farshbaf
Citations per year, relative to Masoud Farshbaf Masoud Farshbaf (= 1×) peers Chang‐Moon Lee

Countries citing papers authored by Masoud Farshbaf

Since Specialization
Citations

This map shows the geographic impact of Masoud Farshbaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masoud Farshbaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masoud Farshbaf more than expected).

Fields of papers citing papers by Masoud Farshbaf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masoud Farshbaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masoud Farshbaf. The network helps show where Masoud Farshbaf may publish in the future.

Co-authorship network of co-authors of Masoud Farshbaf

This figure shows the co-authorship network connecting the top 25 collaborators of Masoud Farshbaf. A scholar is included among the top collaborators of Masoud Farshbaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masoud Farshbaf. Masoud Farshbaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farshbaf, Masoud, et al.. (2024). Synthesis of High-Strength TPU/MXene Nanocomposites via an In Situ Polymerization Method. Macromolecules. 57(9). 3993–4006. 15 indexed citations
3.
Farshbaf, Masoud, Mohammad Dahri, Moein Masjedi, et al.. (2023). 3D Printing of Dental Prostheses: Current and Emerging Applications. Journal of Composites Science. 7(2). 80–80. 55 indexed citations
4.
Salazar, Felix B., et al.. (2023). 89 Non-invasive imaging of tumor-infiltrating B lymphocytes in a triple negative breast cancer model using anti-CD20 immunoPET. SHILAP Revista de lepidopterología. A102–A102. 1 indexed citations
5.
Farshbaf, Masoud, Solmaz Mojarad-Jabali, Salar Hemmati, et al.. (2022). Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers. Journal of Controlled Release. 345. 371–384. 50 indexed citations
6.
Mojarad-Jabali, Solmaz, Masoud Farshbaf, Muhammad Sarfraz, et al.. (2022). Transferrin receptor-mediated liposomal drug delivery: recent trends in targeted therapy of cancer. Expert Opinion on Drug Delivery. 19(6). 685–705. 39 indexed citations
7.
Mojarad-Jabali, Solmaz, Masoud Farshbaf, Salar Hemmati, et al.. (2021). Comparison of three synthetic transferrin mimetic small peptides to promote the blood–brain barrier penetration of vincristine liposomes for improved glioma targeted therapy. International Journal of Pharmaceutics. 613. 121395–121395. 45 indexed citations
8.
Mojarad-Jabali, Solmaz, Masoud Farshbaf, Paul R. Walker, et al.. (2021). An update on actively targeted liposomes in advanced drug delivery to glioma. International Journal of Pharmaceutics. 602. 120645–120645. 87 indexed citations
9.
Zakeri‐Milani, Parvin, Mehdi Soleymani-Goloujeh, Ali Mohammadi, et al.. (2021). Effects of self-assembled cell-penetrating peptides and their nano-complexes on ABCB1 expression and activity.. SHILAP Revista de lepidopterología. 24(3). 383–390. 2 indexed citations
10.
Zakeri‐Milani, Parvin, Ali Nokhodchi, Samad Mussa Farkhani, et al.. (2020). Self-assembled peptide nanoparticles for efficient delivery of methotrexate into cancer cells. Drug Development and Industrial Pharmacy. 46(4). 521–530. 8 indexed citations
11.
Farshbaf, Masoud, Ahmad Yari Khosroushahi, Solmaz Mojarad-Jabali, et al.. (2020). Cell surface GRP78: An emerging imaging marker and therapeutic target for cancer. Journal of Controlled Release. 328. 932–941. 82 indexed citations
12.
Azizi, Mehdi, Hassan Dianat‐Moghadam, Roya Salehi, et al.. (2020). Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications. Advanced Functional Materials. 30(19). 44 indexed citations
13.
Farshbaf, Masoud, et al.. (2018). Recent Advances of Gold Nanoparticles in Biomedical Applications: State of the Art. Cell Biochemistry and Biophysics. 77(2). 123–137. 106 indexed citations
14.
Panahi, Yunes, et al.. (2018). Biotechnological applications of nanomaterials for air pollution and water/wastewater treatment. Materials Today Proceedings. 5(7). 15550–15558. 26 indexed citations
15.
Farshbaf, Masoud, Roya Salehi, Nasim Annabi, et al.. (2017). pH- and thermo-sensitive MTX-loaded magnetic nanocomposites: synthesis, characterization, and in vitro studies on A549 lung cancer cell and MR imaging. Drug Development and Industrial Pharmacy. 44(3). 452–462. 33 indexed citations
16.
Farshbaf, Masoud, Nasim Annabi, Taras Kavetskyy, et al.. (2017). Magnetic carbon nanotubes: preparation, physical properties, and applications in biomedicine. Artificial Cells Nanomedicine and Biotechnology. 46(7). 1314–1330. 63 indexed citations
17.
Farshbaf, Masoud, Soodabeh Davaran, Amir Zarebkohan, et al.. (2017). Significant role of cationic polymers in drug delivery systems. Artificial Cells Nanomedicine and Biotechnology. 46(8). 1–20. 79 indexed citations
18.
Farshbaf, Masoud, Soodabeh Davaran, Fariborz Rahimi, et al.. (2017). Carbon quantum dots: recent progresses on synthesis, surface modification and applications. Artificial Cells Nanomedicine and Biotechnology. 46(7). 1331–1348. 190 indexed citations
19.
Farshbaf, Masoud, et al.. (2016). Magnetic nanoparticles: preparation methods, applications in cancer diagnosis and cancer therapy. Artificial Cells Nanomedicine and Biotechnology. 45(1). 6–17. 77 indexed citations
20.
Panahi, Yunes, Majid Mohammadhosseini, Kazem Nejati‐Koshki, et al.. (2016). Preparation, Surface Properties, and Therapeutic Applications of Gold Nanoparticles in Biomedicine. Drug Research. 67(2). 77–87. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026